Unlock instant, AI-driven research and patent intelligence for your innovation.

Preventive and/or ameliorative agent for diseases, stamina enhancement agent, Anti-fatigue agent, and pharmaceutical and food and drink using them

a technology of anti-fatigue agent and prevention and/or amelioration agent, which is applied in the direction of immunological disorders, bacteria based processes, metabolism disorders, etc., can solve the problems of difficult long-term use and adverse effects of using, and achieve superior efficacy and safety, improve performance, and improve the effect of health conditions of non-healthy subjects

Inactive Publication Date: 2012-02-23
TFK CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a preventive and / or ameliorative agent for inflammatory diseases, allergic diseases, and autoimmune diseases, as well as a stamina enhancement agent and anti-fatigue agent, using purple non-sulfur bacteria and a culture material obtained by culturing them. These purple non-sulfur bacteria have activities of suppressing ulcer formation, inflammation, swelling, and allergic reaction, and also have high safety. The invention is based on the discovery of novel purple non-sulfur bacteria and their activities."

Problems solved by technology

Conventionally, many preventive and / or ameliorative agents for inflammatory diseases, allergic diseases, autoimmune diseases, and the like, stamina enhancement agents, and anti-fatigue agents have had not only advantageous effects but also adverse effects, whereby it has been difficult to use them for a long term.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preventive and/or ameliorative agent for diseases, stamina enhancement agent, Anti-fatigue agent, and pharmaceutical and food and drink using them
  • Preventive and/or ameliorative agent for diseases, stamina enhancement agent, Anti-fatigue agent, and pharmaceutical and food and drink using them
  • Preventive and/or ameliorative agent for diseases, stamina enhancement agent, Anti-fatigue agent, and pharmaceutical and food and drink using them

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0155]In the present example, effects of purple non-sulfur bacteria on inflammatory bowel diseases were histologically evaluated using model mice with colitis induced by dextran sulfate sodium (DSS).

[0156](Culture of Bacterial Cell)

[0157]First, 0.4% by weight sodium acetate and 5% by weight sucrose were added to a basal medium having the composition shown in Table 4, which then was adjusted to pH 7.0. Thus, a medium for bacterial cell was prepared. The medium for bacterial cell was placed in a sealed and illuminated culture vessel. Then a 20% by volume bacterial suspension of Rhodobacter azotoformans BP0899 (Accession No. NITE BP-644) with a bacterial concentration of 1×106 cells / cm3 was added to the medium, which then was subjected to spinner culture at 30° C. for 7 days. Bacterial cells were collected from a culture solution obtained after the spinner culture using a continuous centrifugal separator (sharpless type). Then the bacterial cells were adjusted to 1×1011 cells / cm3 and c...

example 2

[0165]Water and feed were administered into five 5-week-old female ICR mice (purchased from Japan SLC, Inc.) in the same manner as in Example 1 except that the period of ingesting the water containing no DSS and the feed containing bacterial cells was 4 weeks. Then histological evaluations of ulcer formation and a regenerated epithelium were conducted.

example 3

[0172]In the present example, effects of the administration amount of purple non-sulfur bacteria on inflammatory bowel diseases were histologically evaluated using model mice with colitis induced by dextran sulfate sodium (DSS).

[0173](Preparation of Bacterial Cell Powder)

[0174]In the present example, a bacterial cell powder was prepared in the same manner as in Example 1.

[0175](Oral Administration Test)

[0176]In an oral administration test, 3 groups (2 to 4 mice for each group) of 5-week-old female ICR mice (purchased from Japan SLC, Inc.) were used. For induction of colitis in the mice, a DSS-containing water containing 5 w / v % of dextran sulfate sodium (having the molecular weight from 36000 to 50000, manufactured by ICN biomedicals, Inc.) was prepared. The mice in each of the groups ingested the DSS-containing water ad libitum, and the predetermined amounts (1, 6, and 10 mg / kg, p.o.) of the same bacterial cell powder as in Example 1 were administered into the respective mice once ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

A purple non-sulfur bacteria useful in preventing and / or ameliorating at least one disease selected from the group consisting of inflammatory diseases, allergic diseases, and autoimmune diseases and having high safety is provided. A preventive and / or ameliorative agent is for at least one disease selected from the group consisting of inflammatory diseases, allergic diseases, and autoimmune diseases and includes at least one of a purple non-sulfur bacteria and a culture material obtained by culturing the purple non-sulfur bacteria. The purple non-sulfur bacteria includes Rhodobacter azotoformans.

Description

TECHNICAL FIELD[0001]The present invention relates to a preventive and / or ameliorative agent for diseases, a stamina enhancement agent, and an anti-fatigue agent, a pharmaceutical and a food and drink, using them.BACKGROUND ART[0002]It is known that the balance in a network of an immune system, a nervous system, an endocrine system, and the like is important for homeostasis in a biological body. It is believed that a cause of developing diseases such as inflammatory diseases, allergic diseases, autoimmune diseases, cancers, and infectious diseases is a disturbance of the balance in this network. There are various types of fatigue ranging from fatigue associated with serious diseases such as malignant tumors, infectious diseases, and chronic fatigue syndromes to general fatigue caused by mental stresses or physical stresses in daily life.[0003]Conventionally, many preventive and / or ameliorative agents for inflammatory diseases, allergic diseases, autoimmune diseases, and the like, st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K35/74A61K9/14A61P37/08A61P37/06C12N1/20A61P29/00
CPCA23L1/3014A61K35/74A61K2035/11C12R1/01C12N1/20A23L33/135A61P3/02A61P29/00A61P37/06A61P37/08A61P43/00C12N1/205C12R2001/01A23V2200/304A23V2200/324A61K35/744
Inventor TODA, NOBUHIROHIDAKA, YASUHIROISHIKAWA, MASAAKIKANNO, SHUICHI
Owner TFK CO LTD